{
  "disease_name": "Dopamine beta-hydroxylase deficiency",
  "orpha_code": "230",
  "drugs": [
    {
      "name": "NORTHERA",
      "substance_url": null,
      "substance_id": null,
      "regulatory_url": "/en/drug/regulatory/393920?name=230&mode=orpha&region=",
      "regulatory_id": "393920",
      "orpha_substance_code": "ORPHA:182058",
      "details": [
        "NORTHERA(Tradename                        - 18/02/2014)Disease(s) concernedORPHA:441 Pure autonomic failureORPHA:230 Dopamine beta-hydroxylase deficiencyORPHA:102 Multiple system atrophyORPHA:182058 Primary orthostatic hypotension",
        "NORTHERA(Tradename                        - 18/02/2014)",
        "(Tradename                        - 18/02/2014)",
        "Disease(s) concernedORPHA:441 Pure autonomic failureORPHA:230 Dopamine beta-hydroxylase deficiencyORPHA:102 Multiple system atrophyORPHA:182058 Primary orthostatic hypotension",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/trade_name/393913?name=230&mode=orpha&region=&status=all",
          "text": "NORTHERA",
          "type": "trade_name_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/441",
          "text": "ORPHA:441 Pure autonomic failure",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/230",
          "text": "ORPHA:230 Dopamine beta-hydroxylase deficiency",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/102",
          "text": "ORPHA:102 Multiple system atrophy",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/182058",
          "text": "ORPHA:182058 Primary orthostatic hypotension",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/393920?name=230&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Tradename",
      "manufacturer": null,
      "indication": null,
      "regions": [
        "US"
      ]
    },
    {
      "name": "Droxidopa",
      "substance_url": "/en/drug/substance/393911?name=230&mode=orpha&region=&status=all",
      "substance_id": "393911",
      "regulatory_url": "/en/drug/regulatory/393921?name=230&mode=orpha&region=",
      "regulatory_id": "393921",
      "orpha_substance_code": "ORPHA:182058",
      "details": [
        "Droxidopa(Medicinal product                        - 17/01/2007)Disease(s) concernedORPHA:441 Pure autonomic failureORPHA:230 Dopamine beta-hydroxylase deficiencyORPHA:182058 Primary orthostatic hypotension",
        "Droxidopa(Medicinal product                        - 17/01/2007)",
        "(Medicinal product                        - 17/01/2007)",
        "Disease(s) concernedORPHA:441 Pure autonomic failureORPHA:230 Dopamine beta-hydroxylase deficiencyORPHA:182058 Primary orthostatic hypotension",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/393911?name=230&mode=orpha&region=&status=all",
          "text": "Droxidopa",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/441",
          "text": "ORPHA:441 Pure autonomic failure",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/230",
          "text": "ORPHA:230 Dopamine beta-hydroxylase deficiency",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/182058",
          "text": "ORPHA:182058 Primary orthostatic hypotension",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/393921?name=230&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": null,
      "regions": [
        "US"
      ]
    },
    {
      "name": "NORTHERA",
      "substance_url": null,
      "substance_id": null,
      "regulatory_url": "/en/drug/regulatory/393920?name=230&mode=orpha&region=",
      "regulatory_id": "393920",
      "orpha_substance_code": "ORPHA:182058",
      "details": [
        "NORTHERA(Tradename                        - 18/02/2014)Disease(s) concernedORPHA:441 Pure autonomic failureORPHA:230 Dopamine beta-hydroxylase deficiencyORPHA:102 Multiple system atrophyORPHA:182058 Primary orthostatic hypotension",
        "NORTHERA(Tradename                        - 18/02/2014)",
        "(Tradename                        - 18/02/2014)",
        "Disease(s) concernedORPHA:441 Pure autonomic failureORPHA:230 Dopamine beta-hydroxylase deficiencyORPHA:102 Multiple system atrophyORPHA:182058 Primary orthostatic hypotension",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/trade_name/393913?name=230&mode=orpha&region=&status=all",
          "text": "NORTHERA",
          "type": "trade_name_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/441",
          "text": "ORPHA:441 Pure autonomic failure",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/230",
          "text": "ORPHA:230 Dopamine beta-hydroxylase deficiency",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/102",
          "text": "ORPHA:102 Multiple system atrophy",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/182058",
          "text": "ORPHA:182058 Primary orthostatic hypotension",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/393920?name=230&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Tradename",
      "manufacturer": null,
      "indication": null,
      "regions": [
        "US"
      ]
    },
    {
      "name": "AMATINE",
      "substance_url": null,
      "substance_id": null,
      "regulatory_url": "/en/drug/regulatory/131101?name=230&mode=orpha&region=",
      "regulatory_id": "131101",
      "orpha_substance_code": "ORPHA:182058",
      "details": [
        "AMATINE(Tradename                        - 06/09/1996)Disease(s) concernedORPHA:182058 Primary orthostatic hypotension",
        "AMATINE(Tradename                        - 06/09/1996)",
        "(Tradename                        - 06/09/1996)",
        "Disease(s) concernedORPHA:182058 Primary orthostatic hypotension",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/trade_name/33485?name=230&mode=orpha&region=&status=all",
          "text": "AMATINE",
          "type": "trade_name_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/182058",
          "text": "ORPHA:182058 Primary orthostatic hypotension",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/131101?name=230&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Tradename",
      "manufacturer": null,
      "indication": null,
      "regions": [
        "US"
      ]
    },
    {
      "name": "Droxidopa",
      "substance_url": "/en/drug/substance/393911?name=230&mode=orpha&region=&status=all",
      "substance_id": "393911",
      "regulatory_url": "/en/drug/regulatory/393921?name=230&mode=orpha&region=",
      "regulatory_id": "393921",
      "orpha_substance_code": "ORPHA:182058",
      "details": [
        "Droxidopa(Medicinal product                        - 17/01/2007)Disease(s) concernedORPHA:441 Pure autonomic failureORPHA:230 Dopamine beta-hydroxylase deficiencyORPHA:182058 Primary orthostatic hypotension",
        "Droxidopa(Medicinal product                        - 17/01/2007)",
        "(Medicinal product                        - 17/01/2007)",
        "Disease(s) concernedORPHA:441 Pure autonomic failureORPHA:230 Dopamine beta-hydroxylase deficiencyORPHA:182058 Primary orthostatic hypotension",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/393911?name=230&mode=orpha&region=&status=all",
          "text": "Droxidopa",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/441",
          "text": "ORPHA:441 Pure autonomic failure",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/230",
          "text": "ORPHA:230 Dopamine beta-hydroxylase deficiency",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/182058",
          "text": "ORPHA:182058 Primary orthostatic hypotension",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/393921?name=230&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": null,
      "regions": [
        "US"
      ]
    },
    {
      "name": "Midodrine hydrochloride",
      "substance_url": "/en/drug/substance/33486?name=230&mode=orpha&region=&status=all",
      "substance_id": "33486",
      "regulatory_url": "/en/drug/regulatory/136877?name=230&mode=orpha&region=",
      "regulatory_id": "136877",
      "orpha_substance_code": "ORPHA:182058",
      "details": [
        "Midodrine hydrochloride(Medicinal product                        - 21/06/1985)Disease(s) concernedORPHA:182058 Primary orthostatic hypotension",
        "Midodrine hydrochloride(Medicinal product                        - 21/06/1985)",
        "(Medicinal product                        - 21/06/1985)",
        "Disease(s) concernedORPHA:182058 Primary orthostatic hypotension",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/33486?name=230&mode=orpha&region=&status=all",
          "text": "Midodrine hydrochloride",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/182058",
          "text": "ORPHA:182058 Primary orthostatic hypotension",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/136877?name=230&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": null,
      "regions": [
        "US"
      ]
    }
  ],
  "processing_timestamp": "2025-07-07T06:03:39.023602",
  "run_number": 1,
  "total_drugs_found": 6,
  "search_url": "https://www.orpha.net/en/drug?diseaseName=Dopamine+beta-hydroxylase+deficiency&orphaCode=230&name=230&region=&mode=orpha&status=all",
  "search_params": {
    "diseaseName": "Dopamine beta-hydroxylase deficiency",
    "orphaCode": "230",
    "name": "230",
    "region": "",
    "mode": "orpha",
    "status": "all"
  }
}